Últimos Artículos de Diabetes, Obesity and Metabolism
- Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model
- Exploring the link between inflammation and brain function after metabolic‐bariatric surgery: A year‐long fMRI study
- Prognostic value of changes in vibration‐controlled transient elastography parameters for liver, cardiovascular and mortality outcomes in individuals with type 2 diabetes and metabolic dysfunction‐associated steatotic liver disease: The Rio de Janeiro type 2 diabetes cohort
- Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP‐1 receptor dual agonist
- Baseline and cumulative Chinese visceral adiposity index and diabetic kidney disease: A prospective cohort study
- Apolipoprotein CIII correlates with lipoproteins in the fed state and is not regulated by leptin administration in states of hypoleptinemia induced by acute or chronic energy deficiency: Results from two randomised controlled trials
- Association of changes in the type 2 diabetes and MASLD/related SLD status with risk of developing cardiovascular disease
- Correction to “Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the STEP 1–4 trials”
- Effects of antidiabetic agents on lipid metabolism of skeletal muscle: A narrative review
- Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice
- Unexpected cardiovascular risks of glucagon‐like peptide‐1 receptor agonist and aspirin co‐administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study
- Effects of the SGLT2 inhibitor ipragliflozin and metformin on hepatic steatosis and liver fibrosis: Sub‐analysis of a randomized controlled study
- Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial
- Risk of insulin initiation with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes mellitus: A real‐world claims database study in Japan
- Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population‐based study
- Beta cell function and global glucose metabolism are impaired in Dp(16)1Yey mouse model of Down syndrome
- Chemerin loss‐of‐function attenuates glucagon‐like peptide‐1 secretion in exercised obese mice
- Correction to “Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study”
- Impact of a very low‐calorie ketogenic diet on metabolic and microbiota outcomes in post‐bariatric patients and bariatric‐Naïve individuals: A comparative pilot study
- Real‐world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide (SEMA‐elderly)